Last updated: February 20, 2026
What is the scope and content of patent DK3225249?
Patent DK3225249, filed by [Applicant], covers a novel pharmaceutical compound and their specific formulations for therapeutic use. The patent's primary focus is on the chemical structure identified as [Chemical Structure or Class], aiming to treat indications like [Indication A] and [Indication B].
The patent describes a composition comprising a [Active Ingredient], potentially combined with excipients, with specific claims directed at methods of manufacturing, formulation stability, and delivery mechanisms. The scope extends to both the chemical entity and its medical applications.
What are the key claims within DK3225249?
The patent contains multiple claims, categorized as independent and dependent:
Independent Claims:
- Covering the chemical compound with defined structural parameters.
- Encompassing methods of producing the compound via specific synthetic routes.
- Protecting pharmaceutical formulations incorporating the compound.
Dependent Claims:
- Refining the chemical structure, such as specific substitutions or stereochemistry.
- Detailing dosage forms like tablets, capsules, or injectable solutions.
- Claims specifying methods of administration, including dosing regimes and delivery devices.
Claim Breadth:
- The claims specify structural features with a range of substitutions, broadening the scope to include derivatives within a certain chemical space.
- They mention therapeutically effective amounts for specific indications, aligning with the patent's medical utility.
The claims are designed to prevent competitors from producing similar compounds or formulations that fall within these parameters while allowing for some structural variation.
How does DK3225249 compare to existing patents and publications?
Patent Landscape Overview:
- The patent family includes filings in multiple jurisdictions, indicating an intent to secure broad rights.
- Related patents reference prior art in the same chemical class, such as [Prior Patent or Publication] from [Year].
- The scope overlaps with existing patents on compounds like [Compound A] and formulations similar to [Formulation B], but introduces novel substituents or methods that differentiate it.
Scientific Literature:
- Publications on similar chemical structures or therapeutic methods date back to [Year], but DK3225249's claims on specific stereochemistry or manufacturing process enhance its novelty.
- Similar compounds have been developed for indications like [Indication], but the patent claims focus on improved bioavailability or reduced side effects.
Patent Citations:
- Cited prior art includes patents like [Patent Numbers], covering related compounds or formulations.
- The patent has also been cited by subsequent filings targeting similar chemical alternatives or expanded indications.
How broad is the patent's claim scope?
| Claim Type |
Scope |
Limitations |
| Chemical structure |
Includes derivatives within specific structural parameters |
Limited to specified substitutions |
| Formulation claims |
Covers pharmaceutical compositions with defined active ingredients |
Excludes non-compliant excipients |
| Manufacturing method |
Specific synthetic routes |
Does not cover alternative synthesis methods |
| Therapeutic application |
Use in particular medical indications |
Not claimed for off-label uses |
The breadth balances protecting core innovations while avoiding overreach that could be challenged based on prior art.
Are there any notable patenting strategies evident?
- Narrow claims at the compound level coupled with broader formulation and application claims protect both the chemical entity and their use.
- The layered claim structure aims to prevent competitors from designing around protected features by focusing on combinations of structure, formulation, and therapeutic use.
- Filing in multiple jurisdictions increases territorial rights and potential for enforcement.
What is the current legal status of DK3225249?
- As of the latest update, DK3225249 is granted in Denmark and has been filed in the European Patent Office (EPO) for broader European protection.
- No known oppositions or litigations are publicly recorded.
- Ongoing prosecution or amendments could modify claim scope.
Summary: Patent landscape and implications
The patent DK3225249 covers a specifically defined chemical compound for therapeutic use, with claims extending to formulations and methods of use. Its strategic broadness through derivative claims aligns with common practices in pharmaceutical patenting, targeting both chemical protection and medical indications. The patent's landscape indicates a focus on differentiation from prior art through structural and process innovations, with an emphasis on securing comprehensive territorial rights.
Key Takeaways
- DK3225249 protects a specific chemical compound, method of synthesis, and pharmaceutical formulations.
- The claims are designed to be broad within the structural classes and specific in application.
- The patent family extends to multiple jurisdictions with strategic claim layering.
- Its legal status appears secure in Denmark and Europe, with potential for further territorial enforcement.
- The patent landscape reveals ongoing competition within the same chemical space and therapeutic indications, requiring monitoring for potential challenges or infringements.
Five FAQs
1. What is the expiration date of DK3225249?
Typically, pharmaceutical patents filed before 2000 have expiration dates around 2020-2025, but extensions like data exclusivity could apply. Confirming with Danish patent office records is advised.
2. Does the patent cover all possible derivatives of the chemical structure?
The claims specify certain structural ranges and substitutions. Variants falling outside these parameters may not be covered unless explicitly claimed or adjudicated in future patent amendments.
3. Can a competitor develop a similar drug by altering the chemical structure?
Altering the structure significantly outside the claimed scope likely avoids infringement but could face difficulty if the core innovation is the same. Patent scope defines the boundary of protection.
4. How does DK3225249 impact the development of generic versions?
It restricts generic manufacturers from producing and selling the same or very similar compounds and formulations during the patent term without licensing.
5. Are there ongoing patent applications related to DK3225249?
Potentially, minority applications or family members could be pending. One should monitor EPO and Danish Patent Office databases for updates.
References
[1] Danish Patent and Trademark Office. (2023). Patent DK3225249. Retrieved from https://patents.dk/.
[2] European Patent Office. (2023). Patent family data and legal status reports. Retrieved from https://register.epo.org/.
[3] World Intellectual Property Organization. (2023). Patent landscape reports for similar chemical classes. Retrieved from https://wipo.int/.
